Archives of Disease in Childhood 2006;91:762-765
ORIGINAL ARTICLE
Adherence to isoniazid preventive chemotherapy: a prospective community based study
Desmond Tutu TB Centre and Department of Paediatrics and Child Health, Tygerberg Childrens Hospital, Stellenbosch University, Cape Town, South Africa
Correspondence to:
Dr B J Marais
Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Health Sciences, Stellenbosch University, PO Box 19063, Tygerberg, 7505, South Africa; bjmarais @sun.ac.za
Background: Current international guidelines recommend 69 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in children exposed to a susceptible strain of M tuberculosis. However, this is dependent on good adherence and retrospective studies have indicated that adherence to unsupervised INH preventive chemotherapy is poor.
Aim: To prospectively document adherence to six months of unsupervised INH monotherapy and outcome in children with household exposure to an adult pulmonary tuberculosis index case.
Methods: From February 2003 to January 2005 in two suburbs of Cape Town, South Africa, all children <5 years old in household contact with an adult pulmonary tuberculosis index case were screened for tuberculosis and given unsupervised INH preventive chemotherapy once active tuberculosis was excluded. Adherence and outcome were monitored.
Results: In total, 217 index cases from 185 households were identified; 274 children <5 years old experienced household exposure, of whom 229 (84%) were fully evaluated. Thirty eight children were treated for tuberculosis and 180 received preventive chemotherapy. Of the children who received preventive chemotherapy, 36/180 (20%) completed
5 months of unsupervised INH monotherapy. During the subsequent surveillance period six children developed tuberculosis: two received no preventive chemotherapy, and four had very poor adherence.
Conclusion: Adherence to six months of unsupervised INH preventive chemotherapy was poor. Strategies to improve adherence, such as using shorter duration multidrug regimens and/or supervision of preventive treatment require further evaluation, particularly in children who are at high risk to progress to disease following exposure.
Abbreviations: HIV, human immunodeficiency virus; INH, isoniazid; PZA, pyrazinamide; RMP, rifampicin; TST, tuberculin skin test
Keywords: adherence; isoniazid; preventive chemotherapy
Relevant Articles
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Arch. Dis. Child. 2006 91: 721.
Arch. Dis. Child. 2006 91: e5.
This article has been cited by other articles:
-
Kruk, A., Gie, R. P., Schaaf, H. S., Marais, B. J.
(2008). Symptom-Based Screening of Child Tuberculosis Contacts: Improved Feasibility in Resource-Limited Settings. Pediatrics
121: e1646-e1652
[Abstract] [Full Text] -
Khan, M
(2007). Non-adherence to tuberculosis treatment. Arch. Dis. Child.
92: 184-185
[Full Text]
eLetters:
Read all eLetters
- Directly observed therapy might improve compliance
- oscar,m jolobe
- ADC Online, 29 Aug 2006 [Full text]
- Non-Adherence to TB treatment
- Murtuza A Khan
- ADC Online, 3 Oct 2006 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



